1982
DOI: 10.1016/s0001-2998(82)80038-x
|View full text |Cite
|
Sign up to set email alerts
|

Renal radiopharmaceuticals—An update

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
3

Year Published

1985
1985
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(17 citation statements)
references
References 121 publications
0
11
0
3
Order By: Relevance
“…One of the important characteristics of this ligand is that it allows functionalization via the carboxylic functional groups simply by using the DTPA-bisanhydride as a precursor (15,23). The DTPA amide derivatives (either bisamides or monoamide) possess the same number of donor atoms (three nitrogens and five oxygens) as DTPAH 5 , with a reduction of ionizable groups. These acyclic ligands have some advantages relative to macrocyclic analogues in biomedical applications because of their much higher complexation rates and their higher flexibility in coordinating cations compared to the macrocyclic compounds, although their generally faster dissociation kinetics and lower thermodynamic stability can constitute serious disadvantages (27).…”
Section: Introductionmentioning
confidence: 99%
“…One of the important characteristics of this ligand is that it allows functionalization via the carboxylic functional groups simply by using the DTPA-bisanhydride as a precursor (15,23). The DTPA amide derivatives (either bisamides or monoamide) possess the same number of donor atoms (three nitrogens and five oxygens) as DTPAH 5 , with a reduction of ionizable groups. These acyclic ligands have some advantages relative to macrocyclic analogues in biomedical applications because of their much higher complexation rates and their higher flexibility in coordinating cations compared to the macrocyclic compounds, although their generally faster dissociation kinetics and lower thermodynamic stability can constitute serious disadvantages (27).…”
Section: Introductionmentioning
confidence: 99%
“…In addition to the weight of a kidney to be transplanted, in the present study, we measured D-FRV and D-SKGFR for size matching. Traditionally, Tc-99m DMSA scintigraphy has been used to detect renal cortical defects, as it may be used for the functional imaging of the proximal tubular mass of renal cortex [16,17,18,19]. The uptake of Tc-99m DMSA is dependent on renal blood flow and on the membrane transport function of proximal renal tubular cells, and is known to be well correlated with effective renal plasma flow, GFR, and creatinine clearance.…”
Section: Discussionmentioning
confidence: 99%
“…Numerous studies in adult and paediatric patients with a wide range of renal function levels have shown a close agreement between the renal plasma clearance of I3'I-Diatrizoate, '311-Iothalamate and '2'I-Iothalamate on the one hand, and that of inulin determined by the classical clearance technique on the other (Skov, 1970;Bianchi, 1972;Chervu & Blaufox, 1982). Since the extrarenal excretion of "'I-Diatrizoate increases with falling GFR, a single injection 13'I-Diatrizoate plasma clearance determined without urine sampling is considered unreliable for accurate GFR measurements (Chamberlain & Sherwood, 1966;Nelson, Brown & Culp, 1973;Bianchi, Donadio & Tramonti, 1981).…”
Section: J Br@chner-mortensenmentioning
confidence: 89%
“…Hardly any of the presently most commonly used indicator substances completely satisfy both requirements at all GFR values, for example, inulin (polyfructusan); the urological contrast agents Diatrizoate and Iothalamate labelled with either I3II or Iz51; and the metal chelates Ethylenediaminetetraacetic acid (EDTA) and Diethylenetriaminepentaacetic acid (DTPA) labelled with 5'Cr and 9ymTc respectively. They all have some extra-renal elimination which in most cases is considered insignificant, but there are only a few studies in man on the distribution and excretion routes for most of these indicator substances at various degrees of renal impairment (Chervu, Freeman & Blaufox, 1974;Chervu & Blaufox, 1982).…”
Section: J Br@chner-mortensenmentioning
confidence: 99%